In the last 12 months, insiders at Trevi Therapeutics, Inc. ($TRVI) filed 120 transactions with the SEC: 0 open-market purchases totaling $0 and 18 sales totaling $1,171,340. Net insider sentiment: net selling.
Trevi Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Makhzoumi Mohamad (Not found) — 2 transactions totaling $2,537,037
- Behbahani Ali (Not found) — 2 transactions totaling $2,537,037
- Florence Anthony A. Jr. (Not found) — 2 transactions totaling $2,537,037
- Chang Carmen (Not found) — 2 transactions totaling $2,537,037
- SANDELL SCOTT D (Not found) — 2 transactions totaling $2,537,037
View all SEC Filings for Trevi Therapeutics, Inc. (TRVI).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Simon Farrell | Chief Commercial Officer | A | Stock Option (right to buy) | 160000 | $0.00 | 160,000.0000 | 145,104,986 | 9999.99% | 0.11% |
| Feb. 19, 2026 | Cassella James V | Chief Development Officer | A | Stock Option (right to buy) | 215000 | $0.00 | 215,000.0000 | 145,104,986 | 9999.99% | 0.15% |
| Feb. 19, 2026 | Galletta Christopher | See Remarks | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 145,104,986 | 9999.99% | 0.02% |
| Feb. 19, 2026 | SCIASCIA THOMAS | Chief Scientific Officer | A | Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 145,104,986 | 9999.99% | 0.06% |
| Feb. 19, 2026 | GOOD JENNIFER L | President & CEO | A | Stock Option (right to buy) | 675000 | $0.00 | 675,000.0000 | 145,104,986 | 9999.99% | 0.47% |
| April 17, 2025 | SANDELL SCOTT D | Not found | X | Common Stock | 1851852 | $1.37 | 13,222,228.0000 | 101,971,873 | 16.29% | 1.82% |
| April 17, 2025 | Chang Carmen | Not found | X | 3.5-Year Common Stock Warrant | 1851852 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 1.82% |
| April 17, 2025 | Chang Carmen | Not found | X | Common Stock | 1851852 | $1.37 | 13,222,228.0000 | 101,971,873 | 16.29% | 1.82% |
| April 17, 2025 | New Enterprise Associates 16, L.P. | Not found | X | 3.5-Year Common Stock Warrant | 1851852 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 1.82% |
| April 17, 2025 | New Enterprise Associates 16, L.P. | Not found | X | Common Stock | 1851852 | $1.37 | 12,273,280.0000 | 101,971,873 | 17.77% | 1.82% |
| April 17, 2025 | Walker Paul Edward | Not found | X | 3.5-Year Common Stock Warrant | 1851852 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 1.82% |
| April 17, 2025 | Walker Paul Edward | Not found | X | Common Stock | 1851852 | $1.37 | 13,222,228.0000 | 101,971,873 | 16.29% | 1.82% |
| April 17, 2025 | Makhzoumi Mohamad | Not found | X | 3.5-Year Common Stock Warrant | 1851852 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 1.82% |
| April 17, 2025 | Makhzoumi Mohamad | Not found | X | Common Stock | 1851852 | $1.37 | 13,222,228.0000 | 101,971,873 | 16.29% | 1.82% |
| April 17, 2025 | BASKETT FOREST | Not found | X | 3.5-Year Common Stock Warrant | 1851852 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 1.82% |
| April 17, 2025 | BASKETT FOREST | Not found | X | Common Stock | 1851852 | $1.37 | 12,273,280.0000 | 101,971,873 | 17.77% | 1.82% |
| April 17, 2025 | Behbahani Ali | Not found | X | 3.5-Year Common Stock Warrant | 1851852 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 1.82% |
| April 17, 2025 | Behbahani Ali | Not found | X | Common Stock | 1851852 | $1.37 | 13,222,228.0000 | 101,971,873 | 16.29% | 1.82% |
| April 17, 2025 | Florence Anthony A. Jr. | Not found | X | 3.5-Year Common Stock Warrant | 1851852 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 1.82% |
| April 17, 2025 | Florence Anthony A. Jr. | Not found | X | Common Stock | 1851852 | $1.37 | 13,222,228.0000 | 101,971,873 | 16.29% | 1.82% |
| April 17, 2025 | SANDELL SCOTT D | Not found | X | 3.5-Year Common Stock Warrant | 1851852 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 1.82% |
| Jan. 8, 2026 | HASTINGS DAVID C | Chief Financial Officer | A | Stock Option (right to buy) | 375000 | $0.00 | 375,000.0000 | 145,104,986 | 9999.99% | 0.26% |
| Dec. 2, 2025 | Galletta Christopher | See Remarks | M | Stock Option (right to buy) | 4225 | $0.00 | 15,775.0000 | 145,104,986 | 21.13% | 0.00% |
| Dec. 2, 2025 | Galletta Christopher | See Remarks | M | Common Stock | 4225 | $0.51 | 26,095.0000 | 145,104,986 | 19.32% | 0.00% |
| June 11, 2025 | Colangelo Dominick | Not found | A | Nonstatutory Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 101,971,873 | 9999.99% | 0.04% |
| June 11, 2025 | Heffernan Michael Thomas | Not found | A | Nonstatutory Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 101,971,873 | 9999.99% | 0.04% |
| June 11, 2025 | VANLENT ANNE | Not found | A | Nonstatutory Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 101,971,873 | 9999.99% | 0.04% |
| June 11, 2025 | Meeker David P | Not found | A | Nonstatutory Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 101,971,873 | 9999.99% | 0.04% |
| June 11, 2025 | Mathers Edward T | Not found | A | Nonstatutory Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 101,971,873 | 9999.99% | 0.04% |
| May 31, 2025 | Delfini Lisa | Chief Financial Officer | A | Performance Stock Option (right to buy) | 72000 | $0.00 | 110,400.0000 | 101,971,873 | 187.50% | 0.07% |
| May 31, 2025 | GOOD JENNIFER L | President & CEO | A | Performance Stock Option (right to buy) | 102000 | $0.00 | 156,400.0000 | 101,971,873 | 187.50% | 0.10% |
| May 31, 2025 | Galletta Christopher | See Remarks | A | Performance Stock Option (right to buy) | 8550 | $0.00 | 13,110.0000 | 101,971,873 | 187.50% | 0.01% |
| May 31, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | A | Performance Stock Option (right to buy) | 60000 | $0.00 | 92,000.0000 | 101,971,873 | 187.50% | 0.06% |
| May 31, 2025 | Simon Farrell | Chief Commercial Officer | A | Performance Stock Option (right to buy) | 72000 | $0.00 | 110,400.0000 | 101,971,873 | 187.50% | 0.07% |
| March 25, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | M | Stock Option (right to buy) | 2631 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 0.00% |
| March 25, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | M | Common Stock | 2631 | $1.43 | 224,004.0000 | 101,971,873 | 1.19% | 0.00% |
| March 25, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | S | Common Stock | 2631 | $6.60 | 221,373.0000 | 101,971,873 | 1.17% | 0.00% |
| March 21, 2025 | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 5263 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 0.01% |
| March 21, 2025 | GOOD JENNIFER L | President & CEO | M | Common Stock | 5263 | $1.43 | 218,576.0000 | 101,971,873 | 2.47% | 0.01% |
| March 21, 2025 | GOOD JENNIFER L | President & CEO | S | Common Stock | 5263 | $6.58 | 213,313.0000 | 101,971,873 | 2.41% | 0.01% |
| March 10, 2025 | Galletta Christopher | See Remarks | A | Performance Stock Option (right to buy) | 4560 | $0.00 | 4,560.0000 | 101,971,873 | 9999.99% | 0.00% |
| March 10, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | A | Performance Stock Option (right to buy) | 32000 | $0.00 | 32,000.0000 | 101,971,873 | 9999.99% | 0.03% |
| March 10, 2025 | Delfini Lisa | Chief Financial Officer | A | Performance Stock Option (right to buy) | 38400 | $0.00 | 38,400.0000 | 101,971,873 | 9999.99% | 0.04% |
| March 10, 2025 | GOOD JENNIFER L | President & CEO | A | Performance Stock Option (right to buy) | 54400 | $0.00 | 54,400.0000 | 101,971,873 | 9999.99% | 0.05% |
| March 10, 2025 | Simon Farrell | Chief Commercial Officer | M | Stock Option (right to buy) | 31250 | $0.00 | 18,750.0000 | 101,971,873 | 62.50% | 0.03% |
| March 10, 2025 | Simon Farrell | Chief Commercial Officer | M | Stock Option (right to buy) | 63813 | $0.00 | 11,187.0000 | 101,971,873 | 85.08% | 0.06% |
| March 10, 2025 | Simon Farrell | Chief Commercial Officer | M | Performance Stock Option (right to buy) | 17500 | $0.00 | 0.0000 | 101,971,873 | 100.00% | 0.02% |
| March 10, 2025 | Simon Farrell | Chief Commercial Officer | A | Performance Stock Option (right to buy) | 38400 | $0.00 | 38,400.0000 | 101,971,873 | 9999.99% | 0.04% |
| March 10, 2025 | Simon Farrell | Chief Commercial Officer | S | Common Stock | 4350 | $7.15 | 76,900.0000 | 101,971,873 | 5.35% | 0.00% |
| March 10, 2025 | Simon Farrell | Chief Commercial Officer | S | Common Stock | 76963 | $6.73 | 81,250.0000 | 101,971,873 | 48.65% | 0.08% |
| March 10, 2025 | Simon Farrell | Chief Commercial Officer | M | Common Stock | 31250 | $0.51 | 158,213.0000 | 101,971,873 | 24.61% | 0.03% |
| March 10, 2025 | Simon Farrell | Chief Commercial Officer | M | Common Stock | 63813 | $3.91 | 126,963.0000 | 101,971,873 | 101.05% | 0.06% |
| March 10, 2025 | Simon Farrell | Chief Commercial Officer | M | Common Stock | 17500 | $3.21 | 63,150.0000 | 101,971,873 | 38.34% | 0.02% |
| Feb. 18, 2025 | Simon Farrell | Chief Commercial Officer | A | Stock Option (right to buy) | 225500 | $0.00 | 225,500.0000 | 101,971,873 | 9999.99% | 0.22% |
| Feb. 18, 2025 | Delfini Lisa | Chief Financial Officer | A | Stock Option (right to buy) | 225500 | $0.00 | 225,500.0000 | 101,971,873 | 9999.99% | 0.22% |
| Feb. 18, 2025 | GOOD JENNIFER L | President & CEO | A | Stock Option (right to buy) | 811000 | $0.00 | 811,000.0000 | 101,971,873 | 9999.99% | 0.80% |
| Feb. 18, 2025 | Galletta Christopher | See Remarks | A | Stock Option (right to buy) | 41000 | $0.00 | 41,000.0000 | 101,971,873 | 9999.99% | 0.04% |
| Feb. 18, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | A | Stock Option (right to buy) | 116000 | $0.00 | 116,000.0000 | 101,971,873 | 9999.99% | 0.11% |
| Feb. 18, 2025 | Cassella James V | Chief Development Officer | A | Stock Option (right to buy) | 257500 | $0.00 | 257,500.0000 | 101,971,873 | 9999.99% | 0.25% |
| Jan. 7, 2025 | Delfini Lisa | Chief Financial Officer | M | Common Stock | 1000 | $0.51 | 59,660.0000 | 101,971,873 | 1.70% | 0.00% |
| Jan. 7, 2025 | Delfini Lisa | Chief Financial Officer | M | Stock Option (right to buy) | 1000 | $0.00 | 47,125.0000 | 101,971,873 | 2.08% | 0.00% |
| Jan. 8, 2025 | Delfini Lisa | Chief Financial Officer | M | Common Stock | 5000 | $0.51 | 64,660.0000 | 101,971,873 | 8.38% | 0.00% |
| Jan. 8, 2025 | Delfini Lisa | Chief Financial Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 42,125.0000 | 101,971,873 | 10.61% | 0.00% |
| Dec. 13, 2024 | Galletta Christopher | See Remarks | M | Stock Option (right to buy) | 15000 | $0.00 | 20,000.0000 | 101,282,228 | 42.86% | 0.01% |
| Dec. 13, 2024 | Galletta Christopher | See Remarks | M | Common Stock | 15000 | $0.51 | 19,935.0000 | 101,282,228 | 303.95% | 0.01% |
| Sept. 30, 2024 | Cassella James V | Chief Development Officer | A | Stock Option (right to buy) | 400000 | $0.00 | 400,000.0000 | 99,033,373 | 9999.99% | 0.40% |
| Sept. 9, 2024 | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 1840 | $0.00 | 0.0000 | 99,033,373 | 100.00% | 0.00% |
| Sept. 9, 2024 | GOOD JENNIFER L | President & CEO | S | Common Stock | 1840 | $3.04 | 213,313.0000 | 99,033,373 | 0.86% | 0.00% |
| Sept. 9, 2024 | GOOD JENNIFER L | President & CEO | M | Common Stock | 1840 | $1.43 | 215,153.0000 | 99,033,373 | 0.86% | 0.00% |
| Sept. 6, 2024 | GOOD JENNIFER L | President & CEO | S | Common Stock | 4219 | $3.03 | 213,313.0000 | 99,033,373 | 1.94% | 0.00% |
| Sept. 6, 2024 | GOOD JENNIFER L | President & CEO | M | Common Stock | 4219 | $1.43 | 217,532.0000 | 99,033,373 | 1.98% | 0.00% |
| Sept. 6, 2024 | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 4219 | $0.00 | 1,840.0000 | 99,033,373 | 69.63% | 0.00% |
| Sept. 4, 2024 | GOOD JENNIFER L | President & CEO | M | Common Stock | 10981 | $1.43 | 224,294.0000 | 99,033,373 | 5.15% | 0.01% |
| Sept. 3, 2024 | GOOD JENNIFER L | President & CEO | M | Common Stock | 3863 | $1.43 | 217,176.0000 | 99,033,373 | 1.81% | 0.00% |
| Sept. 3, 2024 | GOOD JENNIFER L | President & CEO | S | Common Stock | 3863 | $3.02 | 213,313.0000 | 99,033,373 | 1.78% | 0.00% |
| Sept. 4, 2024 | GOOD JENNIFER L | President & CEO | S | Common Stock | 10981 | $3.02 | 213,313.0000 | 99,033,373 | 4.90% | 0.01% |
| Sept. 5, 2024 | GOOD JENNIFER L | President & CEO | M | Common Stock | 40277 | $1.43 | 253,590.0000 | 99,033,373 | 18.88% | 0.04% |
| Sept. 5, 2024 | GOOD JENNIFER L | President & CEO | S | Common Stock | 40277 | $3.11 | 213,313.0000 | 99,033,373 | 15.88% | 0.04% |
| Sept. 3, 2024 | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 3863 | $0.00 | 57,317.0000 | 99,033,373 | 6.31% | 0.00% |
| Sept. 4, 2024 | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 10981 | $0.00 | 46,336.0000 | 99,033,373 | 19.16% | 0.01% |
| Sept. 5, 2024 | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 40277 | $0.00 | 6,059.0000 | 99,033,373 | 86.92% | 0.04% |
| Aug. 27, 2024 | Meeker David P | Not found | M | Stock Option (right to buy) | 4555 | $0.00 | 0.0000 | 99,033,373 | 100.00% | 0.00% |
| Aug. 27, 2024 | Meeker David P | Not found | M | Common Stock | 4555 | $1.43 | 357,044.0000 | 99,033,373 | 1.29% | 0.00% |
| Aug. 27, 2024 | Meeker David P | Not found | S | Common Stock | 4555 | $2.93 | 352,489.0000 | 99,033,373 | 1.28% | 0.00% |
| Aug. 19, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | M | Common Stock | 16496 | $1.43 | 236,811.0000 | 99,033,373 | 7.49% | 0.02% |
| Aug. 19, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | S | Common Stock | 16496 | $2.96 | 220,315.0000 | 99,033,373 | 6.97% | 0.02% |
| Aug. 19, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | M | Stock Option (right to buy) | 16496 | $0.00 | 0.0000 | 99,033,373 | 100.00% | 0.02% |
| Aug. 16, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | S | Common Stock | 18660 | $2.76 | 220,315.0000 | 99,033,373 | 7.81% | 0.02% |
| Aug. 14, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | M | Stock Option (right to buy) | 100 | $0.00 | 47,901.0000 | 99,033,373 | 0.21% | 0.00% |
| Aug. 16, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | M | Stock Option (right to buy) | 18660 | $0.00 | 16,496.0000 | 99,033,373 | 53.08% | 0.02% |
| Aug. 15, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | M | Stock Option (right to buy) | 12745 | $0.00 | 35,156.0000 | 99,033,373 | 26.61% | 0.01% |
| Aug. 14, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | M | Common Stock | 100 | $1.43 | 220,415.0000 | 99,033,373 | 0.05% | 0.00% |
| Aug. 14, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | S | Common Stock | 100 | $2.75 | 220,315.0000 | 99,033,373 | 0.05% | 0.00% |
| Aug. 15, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | M | Common Stock | 12745 | $1.43 | 233,060.0000 | 99,033,373 | 5.78% | 0.01% |
| Aug. 15, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | S | Common Stock | 12745 | $2.79 | 220,315.0000 | 99,033,373 | 5.47% | 0.01% |
| Aug. 16, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | M | Common Stock | 18660 | $1.43 | 238,975.0000 | 99,033,373 | 8.47% | 0.02% |
| June 13, 2024 | VANLENT ANNE | Not found | A | Nonstatutory Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 99,033,373 | 9999.99% | 0.03% |
| June 13, 2024 | Colangelo Dominick | Not found | A | Nonstatutory Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 99,033,373 | 9999.99% | 0.03% |
| June 13, 2024 | Meeker David P | Not found | A | Nonstatutory Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 99,033,373 | 9999.99% | 0.03% |
| June 13, 2024 | Heffernan Michael Thomas | Not found | A | Nonstatutory Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 99,033,373 | 9999.99% | 0.03% |
| June 13, 2024 | Cassella James V | Not found | A | Nonstatutory Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 99,033,373 | 9999.99% | 0.03% |
| June 13, 2024 | Mathers Edward T | Not found | A | Nonstatutory Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 99,033,373 | 9999.99% | 0.03% |
| May 29, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | S | Common Stock | 53368 | $2.55 | 214,433.0000 | 99,033,373 | 19.93% | 0.05% |
| May 29, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | M | Stock Option (right to buy) | 59354 | $0.00 | 0.0000 | 99,033,373 | 100.00% | 0.06% |
| May 29, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | M | Common Stock | 59354 | $2.19 | 267,801.0000 | 99,033,373 | 28.47% | 0.06% |
| May 22, 2024 | Delfini Lisa | Chief Financial Officer | M | Stock Option (right to buy) | 16043 | $0.00 | 48,125.0000 | 99,033,373 | 25.00% | 0.02% |
| May 22, 2024 | Delfini Lisa | Chief Financial Officer | S | Common Stock | 4350 | $2.64 | 53,279.0000 | 99,033,373 | 7.55% | 0.00% |
| May 22, 2024 | Delfini Lisa | Chief Financial Officer | M | Common Stock | 16043 | $0.51 | 57,629.0000 | 99,033,373 | 38.58% | 0.02% |
| May 20, 2024 | GOOD JENNIFER L | President & CEO | M | Common Stock | 25037 | $2.19 | 238,350.0000 | 99,033,373 | 11.74% | 0.03% |
| May 20, 2024 | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 25037 | $0.00 | 33,189.0000 | 99,033,373 | 43.00% | 0.03% |
| May 20, 2024 | GOOD JENNIFER L | President & CEO | S | Common Stock | 25037 | $2.86 | 213,313.0000 | 99,033,373 | 10.50% | 0.03% |
| May 10, 2024 | GOOD JENNIFER L | President & CEO | M | Common Stock | 4578 | $2.19 | 217,891.0000 | 99,033,373 | 2.15% | 0.00% |
| May 10, 2024 | GOOD JENNIFER L | President & CEO | M | Stock Option (right to buy) | 4578 | $0.00 | 58,226.0000 | 99,033,373 | 7.29% | 0.00% |
| May 10, 2024 | GOOD JENNIFER L | President & CEO | S | Common Stock | 4578 | $2.90 | 213,313.0000 | 99,033,373 | 2.10% | 0.00% |
| Feb. 15, 2024 | Delfini Lisa | Chief Financial Officer | A | Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 99,033,373 | 9999.99% | 0.18% |
| Feb. 15, 2024 | Clark David J | Chief Medical Officer | A | Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 99,033,373 | 9999.99% | 0.18% |
| Feb. 15, 2024 | Galletta Christopher | See Remarks | A | Stock Option (right to buy) | 28500 | $0.00 | 28,500.0000 | 99,033,373 | 9999.99% | 0.03% |
| Feb. 15, 2024 | Simon Farrell | Chief Commercial Officer | A | Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 99,033,373 | 9999.99% | 0.18% |
| Feb. 15, 2024 | GOOD JENNIFER L | President & CEO | A | Stock Option (right to buy) | 630000 | $0.00 | 630,000.0000 | 99,033,373 | 9999.99% | 0.64% |
| Feb. 15, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 99,033,373 | 9999.99% | 0.15% |